Work

Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14).

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.e21112

Authors: Muhammad Furqan, Siddharth Karanth, Ravi K. Goyal, Yu-Hsuan Shih, Beilei Cai, Julien Rombi, Keith L. Davis, Nydia Caro, Teddy Rassem Saliba

Institutions: University of Iowa, RTI Health Solutions

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Pharmaceuticals Corporation

OpenAlex ID: W4379280705

Cites:

Cited by: 2

Related to: 10